Discriminating Between Non-Specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis at Early Stages: When CPET is Enough?

被引:0
作者
Boutou, Afroditi K. [1 ]
机构
[1] G Papanikolaou Gen Hosp Thessaloniki, Dept Resp Med, Thessaloniki, Greece
关键词
D O I
10.1007/s00408-019-00316-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:243 / 244
页数:2
相关论文
共 5 条
  • [2] Non-invasive markers of pulmonary hypertension in interstitial lung disease: Is cardiopulmonary exercise testing the Holy Grail?
    Boutou, Afroditi K.
    Pitsiou, Georgia G.
    Argyropoulou, Paraskevi
    [J]. RESPIROLOGY, 2014, 19 (05) : 621 - 622
  • [3] Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung disease
    George, Peter M.
    Mitchell, Jane A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2019, 317 (04) : L431 - L433
  • [4] Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease
    Hagmeyer, Lars
    Herkenrath, Simon
    Anduleit, Norbert
    Treml, Marcel
    Randerath, Winfried
    [J]. LUNG, 2019, 197 (06) : 721 - 726
  • [5] Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide
    Rose, Lauren
    Prins, Kurt W.
    Archer, Stephen L.
    Pritzker, Marc
    Weir, E. Kenneth
    Misialek, Jeffrey R.
    Thenappan, Thenappan
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (02) : 145 - 155